Asunto(s)
Negro o Afroamericano , Hiperpigmentación/inducido químicamente , Factores Inmunológicos/efectos adversos , Lenalidomida/efectos adversos , Talidomida/análogos & derivados , Talidomida/efectos adversos , Humanos , Hiperpigmentación/epidemiología , Hiperpigmentación/psicología , Factores Inmunológicos/uso terapéutico , Incidencia , Lenalidomida/uso terapéutico , Mieloma Múltiple/complicaciones , Mieloma Múltiple/tratamiento farmacológico , Especificidad de Órganos , Estudios Retrospectivos , Talidomida/uso terapéuticoRESUMEN
BACKGROUND: Disorders of hyperpigmentation are seen commonly in clinical practice. Despite numerous studies investigating sun-protective habits among healthy persons, little is known about these behaviors within patient populations with hyperpigmentation disorders. OBJECTIVE: We sought to examine photo-protective behaviors and their associations in individuals with disorders of hyperpigmentation. METHODS: This cross-sectional study was conducted with 404 adults who complained of cutaneous hyperpigmentation. RESULTS: About 67.5% reported using a product containing sunscreen, and 91% endorsed using one with a sun protection factor of 21 or higher. Among the participants, 48.5% were not sure if their sunscreen provided broad-spectrum protection, and only 7.6% reapplied every 2 hours. The odds of a patient with melasma using sunscreen were 6.7 times the odds of a patient with postinflammatory hyperpigmentation using sunscreen (P < .001). Additional predictors for sunscreen use were female sex (OR = 3.8, P = .0004) and disease duration of ≥1 year (OR = 2.1, P = .003). In a multivariate analysis, the odds ratio of sunscreen use among African Americans compared to whites was 0.31 (P = .008). LIMITATIONS: Limitations included recall bias, question misinterpretation, and reporter bias. CONCLUSION: Patients diagnosed with postinflammatory hyperpigmentation, men, and those with disease duration <1 year reported lower sunscreen usage. These groups might benefit from increased counseling on sun-protective behaviors.
Asunto(s)
Conductas Relacionadas con la Salud , Hiperpigmentación/psicología , Luz Solar , Protectores Solares/uso terapéutico , Adolescente , Adulto , Negro o Afroamericano/estadística & datos numéricos , Estudios Transversales , Femenino , Conductas Relacionadas con la Salud/etnología , Humanos , Hiperpigmentación/etiología , Inflamación/complicaciones , Masculino , Melanosis/psicología , Persona de Mediana Edad , Factores Sexuales , Factor de Protección Solar , Protectores Solares/administración & dosificación , Factores de Tiempo , Población Blanca/estadística & datos numéricos , Adulto JovenAsunto(s)
Dermatólogos/educación , Hiperpigmentación/patología , Manejo de Atención al Paciente/métodos , Automanejo/educación , Dermatólogos/organización & administración , Humanos , Hiperpigmentación/diagnóstico , Hiperpigmentación/psicología , Melanosis/tratamiento farmacológico , Calidad de Vida , Automanejo/métodos , Factor de Protección Solar/métodos , Encuestas y Cuestionarios , Ácido Tranexámico/uso terapéutico , Reino UnidoRESUMEN
BACKGROUND: There are no validated outcome measures for postinflammatory hyperpigmentation (PIH). OBJECTIVE: We sought to determine the reliability and validity of an outcome measure for PIH after acne in patients with skin of color. METHODS: A postacne hyperpigmentation index (PAHPI) was developed. Six raters scored 21 patients with PIH twice. Reliability was determined within and between raters, whereas validity was evaluated by comparing scores with severity ranking by an independent dermatologist. The pigment intensity scores were compared with the melanin index of each patient using a narrowband reflectance spectrophotometer. A quality-of-life score (Skindex-29) was also compared with PAHPI scores. RESULTS: Total PAHPI scores showed good reliability within and between raters and were valid when compared with clinical severity and melanin indices. Good correlation was achieved between the total PAHPI score and the emotion subscale of the Skindex-29. LIMITATIONS: Generalizability of results is limited to African American females. CONCLUSION: The PAHPI shows good reliability and validity when scored on patients with PIH from acne vulgaris. The PAHPI also correlates well with the emotional impact of PIH as measured by the Skindex-29. Future studies should assess the ability of the PAHPI to change with improvement of PIH from acne after treatment.
Asunto(s)
Acné Vulgar/complicaciones , Hiperpigmentación/etiología , Hiperpigmentación/patología , Índice de Severidad de la Enfermedad , Acné Vulgar/patología , Adolescente , Adulto , Negro o Afroamericano , Pueblo Asiatico , Dermatitis/patología , Femenino , Hispánicos o Latinos , Humanos , Hiperpigmentación/psicología , Masculino , Melaninas/análisis , Variaciones Dependientes del Observador , Calidad de Vida , Reproducibilidad de los Resultados , Espectrofotometría , Adulto JovenAsunto(s)
Hiperpigmentación/fisiopatología , Hiperpigmentación/psicología , Calidad de Vida , Perfil de Impacto de Enfermedad , Adolescente , Adulto , Factores de Edad , Estudios Transversales , Etnicidad/estadística & datos numéricos , Femenino , Humanos , Hiperpigmentación/epidemiología , Masculino , Persona de Mediana Edad , Medición de Riesgo , Factores Sexuales , Adulto JovenRESUMEN
Medical makeup corrects skin tone imperfections with dermo-cosmetic products, which bring together tolerance efficacy, colour neutralization and sun protection. Highly suitable for imperfections caused by hyperpigmentation, it allows patients affected by these disorders to cover them up effectively and discretely, giving them a better quality of life.
Asunto(s)
Cosméticos/uso terapéutico , Hiperpigmentación/terapia , Estética , Humanos , Hiperpigmentación/diagnóstico , Hiperpigmentación/etiología , Hiperpigmentación/psicología , Calidad de Vida/psicología , Pigmentación de la Piel , Protectores Solares/uso terapéuticoRESUMEN
Hyperpigmentations are very frequent situations that can have considerable impact on the quality of life of affected individuals. However, even if the esthetic prejudice they generate is undeniable, lentigo and melasma are benign conditions that require above all a risk-free management. In addition to the dermatological procedures (peeling, laser, etc.) and the topical drugs available to the dermatologist, there remains significant room for depigmenting dermocosmetic products. These products succeeded to transpose features of the classic pharmaceutical formula invented by Kligman from which they were inspired to the field of dermocosmetics. They comprise activators of epidermal turn-over, skin exfoliants, and active ingredients that interfere with the different stages of melanogenesis, without having the side effects of hydroquinone whose usage remains limited to the field of prescription drugs. Antioxidants are a particularly interesting addition because they participate in reducing cutaneous inflammation and efficiently complete the action of the other components of a depigmenting formula. It is important to remind the aggravating role that sun exposure has on hyperpigmentations. Therefore, measures of rigorous photoprotection are mandatory. Medical makeup, transitory or definite, is an interesting option for the management of hyperpigmentations. Consequently, depigmenting dermocosmetics, used in monotherapy but - most frequently - in combination with dermatological procedures, can be used in literally all types of hyperpigmentations with an efficacy that is dependent on the specific etiology. They are suited to be part of a treatment program that has to be adapted on a case-by-case basis.
Asunto(s)
Cosméticos/uso terapéutico , Hiperpigmentación/terapia , Preparaciones para Aclaramiento de la Piel/uso terapéutico , Antioxidantes/uso terapéutico , Terapia Combinada , Humanos , Hiperpigmentación/diagnóstico , Hiperpigmentación/etiología , Hiperpigmentación/psicología , Queratolíticos/uso terapéutico , Lentigo/diagnóstico , Lentigo/etiología , Lentigo/psicología , Lentigo/terapia , Terapia por Luz de Baja Intensidad , Melanosis/diagnóstico , Melanosis/etiología , Melanosis/psicología , Melanosis/terapia , Calidad de Vida/psicología , Protectores Solares/uso terapéuticoRESUMEN
Postinflammatory hyperpigmentation (PIH) is common in patients with skin of color. Notably, the US population of children with skin of color is growing rapidly. Postinflammatory hyperpigmentation can be quite distressing in pediatric patients, particularly among adolescents and their parents/guardians. Therefore, it is crucial that dermatologists can identify and treat underlying inciting inflammatory dermatoses in this patient population. In this article, management strategies for PIH in pediatric patients with skin of color are presented.
Asunto(s)
Dermatitis/complicaciones , Hiperpigmentación/terapia , Pigmentación de la Piel , Adolescente , Niño , Dermatitis/patología , Humanos , Hiperpigmentación/etiología , Hiperpigmentación/psicologíaRESUMEN
INTRODUCTION: Periorbital hyperchromia (POH) is a multifactorial condition, precipitated or aggravated by sleep disorders, which negatively affects quality of life (QoL). The aim of this study was to evaluate the impact of POH on QoL, sleep quality, and dissatisfaction of affected patients. METHODS: In this cross-sectional study of male and female patients over 18 years, participants were examined, their demographic data were registered, and Dermatology Quality of Life Index (DLQI), Pittsburgh Sleep Quality Index (PSQI-BR), and Visual Analogue Scale (VAS) were used to assess dissatisfaction. RESULTS: Patients (n = 100) were mostly women (91%) with a mean age of 36.9 years and POH duration of 18.32 years. Phototypes II (24%) and III (60%) were predominant. A total of 33% reported 4-6 hours and 66% reported over 6 hours of sleep per night. POH was classified as mild (59%), moderate (37%), or severe (4%). Mean dissatisfaction with POH was 6.9, PSQI was 6.04, and DLQI was 4.92. There was a significant difference in the dissatisfaction scale (P < .005) between men and women. Women reported worse QoL (P < .001) and higher dissatisfaction (P < .0001). A correlation between DLQI and disease duration was found. CONCLUSION: Periorbital hyperchromia negatively impacts patients' QoL. Dissatisfaction is directly related to disease severity.
Asunto(s)
Enfermedades de los Párpados/psicología , Párpados/anomalías , Dermatosis Facial/psicología , Hiperpigmentación/psicología , Satisfacción Personal , Calidad de Vida , Sueño , Adulto , Anciano , Estudios Transversales , Estética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Factores de Tiempo , Adulto JovenRESUMEN
Facial concerns in skin of color (SOC) patients vary and can be a source of emotional and psychological distress. This article discusses 4 common facial concerns in SOC patients: acne, rosacea, facial hyperpigmentation, and cosmetic enhancement. Treatment recommendations are provided as well as management pearls.
Asunto(s)
Acné Vulgar/terapia , Técnicas Cosméticas , Hiperpigmentación/terapia , Rosácea/terapia , Acné Vulgar/psicología , Humanos , Hiperpigmentación/psicología , Rosácea/psicología , Pigmentación de la PielRESUMEN
BACKGROUND:: Acne is one of the most common skin diseases. It has significant effect on self-image and negative impact on quality of life. Postinflammatory hyperpigmentation is an acquired hypermelanosis that occurs after a skin injury or cutaneous inflammation. It is common sequelae in acne patients. OBJECTIVES:: This study aimed to investigate the psychosocial impact of acne and postinflammatory hyperpigmentation among patients treated in a dermatology outpatient clinic at the University of Miami Hospital. METHODS:: The study had the participation of 50 patients with acne and postinflammatory hyperpigmentation. All participants volunteered to complete an anonymous questionnaire containing socio-demographical information, questions about patient's attitudes toward postinflammatory hyperpigmentation caused by acne, the Cardiff Acne Disability Index and the Dermatology Life Quality Index. RESULTS:: Postinflammatory hyperpigmentation was more predominant in the face. Makeup was frequently used to conceal the imperfections and the majority of patients felt embarrassed due to their condition. Interestingly, the majority of our patients did not have their quality of life impacted for acne and postinflammatory hyperpigmentation. STUDY LIMITATIONS:: A limitation of the study was the relatively small sample size. For this reason, the findings of the study should not be generalized to the broader community. CONCLUSION:: The current medical literature has many studies analyzing the psychological impact of acne. This study is the first study in the literature that analyzed the psychosocial impact of acne and postinflammatory hyperpigmentation caused by acne.
Asunto(s)
Acné Vulgar/psicología , Hiperpigmentación/psicología , Calidad de Vida , Perfil de Impacto de Enfermedad , Acné Vulgar/complicaciones , Adolescente , Adulto , Femenino , Humanos , Hiperpigmentación/etiología , Masculino , Índice de Severidad de la Enfermedad , Factores Sexuales , Encuestas y Cuestionarios , Adulto JovenRESUMEN
Prominent pigmented fungiform paillae of the tongue are characterized clinically by prominence and pigmentation confined to these papillae and histopathologically by melanophages in the lamina opriae. A 45-year-old Asian woman had dark erythematous papules exclusively involved with fungiform papillae on the anterior lateral dorsal aspect of the tongue and hyperpigmentation on the lip. Histologic examination revealed many melanophages in the subepidermal area within the fungiform papillae. Her skin lesions improved moderately following two months of treatment for anemia.
Asunto(s)
Anemia Ferropénica/complicaciones , Anemia Ferropénica/patología , Hiperpigmentación/etiología , Hiperpigmentación/psicología , Lengua/patología , Femenino , Humanos , Labio/patología , Persona de Mediana EdadRESUMEN
Hyperpigmentation disorders of the skin are common. Three of the more common forms include melasma, lentigines, and post-inflammatory hyperpigmentation. Significant negative psychological consequences can result. Many therapeutic options exist, though treatment is often difficult, requiring lengthy therapy.
Asunto(s)
Hiperpigmentación/etiología , Hiperpigmentación/terapia , Quimioexfoliación , Crioterapia , Fármacos Dermatológicos/uso terapéutico , Ácidos Dicarboxílicos/uso terapéutico , Humanos , Hidroquinonas/uso terapéutico , Hiperpigmentación/clasificación , Hiperpigmentación/psicología , Inflamación , Queratolíticos/uso terapéutico , Terapia por Láser , Lentigo/etiología , Lentigo/terapia , Melanosis/etiología , Melanosis/terapia , Educación del Paciente como Asunto , Prevención Primaria , Factores de Riesgo , Autocuidado , Luz Solar/efectos adversos , Tretinoina/uso terapéuticoRESUMEN
Abstract: Background: Acne is one of the most common skin diseases. It has significant effect on self-image and negative impact on quality of life. Postinflammatory hyperpigmentation is an acquired hypermelanosis that occurs after a skin injury or cutaneous inflammation. It is common sequelae in acne patients. Objectives: This study aimed to investigate the psychosocial impact of acne and postinflammatory hyperpigmentation among patients treated in a dermatology outpatient clinic at the University of Miami Hospital. Methods: The study had the participation of 50 patients with acne and postinflammatory hyperpigmentation. All participants volunteered to complete an anonymous questionnaire containing socio-demographical information, questions about patient's attitudes toward postinflammatory hyperpigmentation caused by acne, the Cardiff Acne Disability Index and the Dermatology Life Quality Index. Results: Postinflammatory hyperpigmentation was more predominant in the face. Makeup was frequently used to conceal the imperfections and the majority of patients felt embarrassed due to their condition. Interestingly, the majority of our patients did not have their quality of life impacted for acne and postinflammatory hyperpigmentation. Study limitations: A limitation of the study was the relatively small sample size. For this reason, the findings of the study should not be generalized to the broader community. Conclusion: The current medical literature has many studies analyzing the psychological impact of acne. This study is the first study in the literature that analyzed the psychosocial impact of acne and postinflammatory hyperpigmentation caused by acne.
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Adulto Joven , Calidad de Vida , Hiperpigmentación/psicología , Acné Vulgar/psicología , Perfil de Impacto de Enfermedad , Índice de Severidad de la Enfermedad , Factores Sexuales , Encuestas y Cuestionarios , Hiperpigmentación/etiología , Acné Vulgar/complicacionesAsunto(s)
Fármacos Dermatológicos/administración & dosificación , Hiperpigmentación/tratamiento farmacológico , Hiperpigmentación/psicología , Adaptación Psicológica , Fármacos Dermatológicos/efectos adversos , Tolerancia a Medicamentos , Femenino , Humanos , Masculino , Satisfacción del Paciente , Peróxidos/uso terapéutico , Resultado del TratamientoRESUMEN
BACKGROUND: Pigmentary disorders are commonly seen in dermatology practice and can have a negative psychosocial impact on patients. OBJECTIVE: This study aims to examine the prevalence of pigmentary disorders and their level of psychological and physical impact on patients. METHODS: A prospective cohort study involved a sample of 140 patients undergoing skin exams at a private dermatology practice in North Carolina. Patient demographics and pigmentary diagnoses were obtained, and participants were asked to fill out a skin discoloration impact evaluation questionnaire. Descriptive and frequency analyses were performed. RESULTS: Around 80% of the participants were diagnosed with one or more pigmentary disorders. About 47.3% of patients admitted of feeling self-conscious about their skin to some degree, 21.8% felt others focused on their skin, 32.7% felt unattractive because of their skin, 32.7% put effort into hiding pigment changes, and 23.6% felt their skin affected their activities. A limitation was the lack of diversity in the population studied (gender and skin type). CONCLUSIONS: Pigmentary disorders such as melasma, vitiligo, and lentigo pose significant negative impact on a person's health-related quality of life. Hence, there is a need for effective treatments of pigmentary disorders based on their prevalence and effect on quality of life. Healthcare providers should consider the impact of pigmentary disorders on health-related quality of life and educate patients on possible treatments.
Asunto(s)
Trastornos de la Pigmentación/epidemiología , Trastornos de la Pigmentación/psicología , Estudios de Cohortes , Femenino , Humanos , Hiperpigmentación/epidemiología , Hiperpigmentación/psicología , Lentigo/epidemiología , Lentigo/psicología , Masculino , Melanosis/epidemiología , Melanosis/psicología , North Carolina/epidemiología , Prevalencia , Estudios Prospectivos , Calidad de Vida , Muestreo , Perfil de Impacto de Enfermedad , Encuestas y Cuestionarios , Vitíligo/epidemiología , Vitíligo/psicologíaRESUMEN
BACKGROUND: Body dysmorphic disorder (BDD) is a syndrome characterized by distress secondary to imagined or minor defects in one's appearance. Although it is a psychiatric disorder, most affected patients present to the dermatologist or plastic surgeon to improve their perceived defect. OBJECTIVE: The objective was to review the literature on BDD, examining the epidemiology, etiology, clinical features, diagnostic criteria, and treatment of the disorder. METHODS: Three representative cases of BDD are presented; in addition, a search of MEDLINE was completed and a review of all published data on BDD was performed. RESULTS: BDD has an estimated prevalence of 1 to 2% in the general population; this prevalence is increased in patient populations. There is significant comorbidity associated with BDD. CONCLUSIONS: BDD is a relatively common psychiatric disorder in which patients typically present to cosmetic surgeons for treatment of their perceived or imagined defect. Surgical treatments usually prove unsatisfactory to the patient and to the practitioner. Psychiatric treatment is extremely challenging.